AI tool tested to lighten Doctors' load in rare cancer reporting
NCT ID NCT06026098
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether an artificial intelligence tool can reduce the mental strain doctors feel when writing case reports about rare tumors. Ten physicians, medical students, or postdoctoral students will write clinical vignettes with and without AI help in a single two-hour session. The goal is to see if AI assistance lowers cognitive workload and improves usability, which could encourage more reporting of rare medical events and ultimately improve care for these patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Artificial Intelligence assistance tool
What this could lead to
If it works, this could help doctors report rare tumor cases more easily, leading to better evidence for treating these conditions.
What could go wrong
This is a very small, early study with only 10 participants, so results may not apply broadly. The AI tool may not reduce workload as hoped.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COGNITIVE SYMPTOM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, 27514, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••